#NAFLD

International NASH Day is a public education campaign launched in June 2018 to raise visibility and urgency around fatty liver disease.

Some 20% of those with NAFLD also showed signs of liver fibrosis.

Experts predict that more than a million people could die from liver cancer worldwide in 2040.

Among people with fatty liver disease, those with diabetes were more likely to advance by one fibrosis stage in less than six years.

Positive results announced by Madrigal Pharmaceuticals could potentially lead to the first drug approval for fatty liver disease.

Women and young adults saw especially large increases between 2019 and 2021.

Black people make up only 6% and Latino people make up 5% of participants in cirrhosis trials in the United States.

Another study found that children with fatty liver disease are at high risk for diabetes.

Diabetes and a large waist circumference are predictors of liver fat accumulation and fibrosis.

People with a tendency to be active later in the day may be at greater risk for severe NAFLD.

The Global Liver Institute’s “Global State of Liver Health” identifies liver disease trends around the world and proposes solutions.

Non-alcoholic fatty liver disease is substantially more common among men compared with women.

People with NAFLD who had heart disease or had a stroke had higher rates of dementia.

Second- and third-generation individuals in Los Angeles had a 35% and 61% higher risk, respectively, than those born in Mexico.

Liver cancer is now less likely to be caused by hepatitis B or C, but more likely to be caused by fatty liver disease or alcohol.

Despite not cutting back on calories, people on the high fat diet lost more weight and had better blood sugar levels.